Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mupirocin for nasal Staphylococcus aureus decolonization and prevention of ICU infection
IRCT2013110915327N1Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of mupirocin in staphylococcal carrier state and Healthcare-associated infection (HAI), sponsored by Arak University of Medical Sciences. Started Nov 2013; status: completed.
02
Drugs
mupirocin
03
Conditions
staphylococcal carrier stateHealthcare-associated infection (HAI)
Beyond the preview
Go deeper on IRCT2013110915327N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013110915327N1.